Target Audience: The program is designed for and most benefit basic science and medical researchers, cardiologists, ophthalmic surgeons, neurologists, neurosurgeons, orthopedics, oncologists, urologists, and other physicians; as well as registered nurses and nurse practititioners, certified nurse midwives, and allied health professionals interested in the field of stem cell biology and therapy.

Objectives:

Upon completion of this program, participants should be able to:

2) understand the ethical issues concerning stem cell therapeutics

3) participate using stem cells in preclinical and clinical trials

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of William Beaumont Hospital and Oakland University.   The William Beaumont Hospital is accredited by the ACCME to provide continuing medical education for physicians.

Credit Statement: William Beaumont Hospital designates this educational activity for a maximum of 13.75 AMA PRA Category 1 credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Statement: All planning committee members and speakers have been asked to disclose any relative relationships they may have with the commercial entities, as well as any intent they may have to discuss off-label uses of pharmaceuticals or medical techniques/equipment. The presence or absence of relationships, or intent to speak of off-label uses, will be disclosed at the time of the meeting